Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer.
-
Published:2024-09
Issue:
Volume:
Page:217219
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
Chica-Parrado María Rosario,
Kim Gun Min,
Uemoto YasuakiORCID,
Napolitano FabianaORCID,
Lin Chang-Ching,
Ye Dan,
Bikorimana Emmanuel,
Fang YishengORCID,
Lee Kyung-min,
Mendiratta Saurabh,
Hanker Ariella B.,
Arteaga Carlos L.